leisure time -WSS

leisure time

author：comprehensive 2025-09-30 00:03:37 - browse：68

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

The Food and Drug Administration on Thursday approved an Eli Lilly drug that takes a new approach to treating ulcerative colitis, a chronic inflammatory disease that can cause intense gastrointestinal pain and distress.

The therapy, dubbed Omvoh, is an antibody that blocks IL-23p19, an immune signaling molecule that plays a key role in sustaining the disease. It’s the first treatment to target this particular pathway in ulcerative colitis. The drug’s approval comes after two late-stage trials found that patients taking Omvoh showed a significant improvement in symptoms after both three months and a year compared with those given a placebo, and that the therapy had minimal side effects.

Omvoh’s list price will be $9,593 per month for intravenous delivery and $10,360 per dose injected beneath the skin. A company spokesperson told STAT that patients who have the drug covered by commercial insurance may pay as little as $5 per month for up to 30 months.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： NIH confirmation hearing shows politicization of research

knowledge

WSS

ProMED, early warning system on disease outbreaks, in peril

FDA struggles to regulate food additives, sometimes for decades

Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

White House drug shortage group privately met with industry

Humana, CVS hope to turn members into patients at clinics

Wild otter attack leads to woman being airlifted to hospital, 2 others treated for injuries

explore

leisure time

hotspot

George Santos makes 1st court appearance after pleading not guilty to 13 counts

How climate

After affirmative action ruling, medical educators look to 'holistic review'

UnitedHealth’s board chair also owns a personal investment firm

Medical leaders decry Supreme Court decision on affirmative action

What Mike Pence has said that could be used in a Donald Trump trial

Malaria cases in Florida and Texas: Here’s what you need to know

Verily hires former Apple Health leader as chief scientific officer

What does generative AI mean for health care? We asked experts

For BCIs, commercial hurdles may be bigger than scientific ones

explore

2023 STAT Wunderkinds: get to know the winners

STAT Summit: How a Chicago ER doctor tackles gun violence

Nearly two

Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

Nearly two

My superpower is killing ticks

explore

knowledge

explore

focus